NEW YORK (GenomeWeb) – GeneNews yesterday after the close of the market reported a sharp increase year over year in its fourth quarter revenues.

For the three months ended Dec. 31, 2014, GeneNews' total revenues jumped to C$701,000 (US$555,844) from C$37,000 in the prior-year period.

The firm attributed the growth in revenue to a 50 percent increase in ColonSentry test volume in the second half of the fiscal year. The firm's jointly owned US Innovative Diagnostic Laboratory processed 14,387 ColonSentry tests in Q4 2014. The firm has a 33 percent share in the joint venture.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.